BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2928998)

  • 21. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
    Larsson K; Hjemdahl P
    Thorax; 1989 Sep; 44(9):767-8. PubMed ID: 2627224
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.
    Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G
    Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.
    Newhouse MT; Dolovich MB; Kazim F
    Chest; 1994 Jun; 105(6):1738-42. PubMed ID: 8205869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiopulmonary effects of fenoterol and salbutamol aerosols.
    Tandon MK
    Chest; 1980 Mar; 77(3):429-31. PubMed ID: 7357948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac and pulmonary effects of therapy with albuterol and isoproterenol.
    Whitsett TL; Manion CV
    Chest; 1978 Sep; 74(3):251-5. PubMed ID: 357097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol.
    Larsson S; Svedmyr N
    Ann Allergy; 1977 Nov; 39(5):362-6. PubMed ID: 921004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
    Marlin GE; Turner P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma.
    Bauer K; Dietersdorfer F; Sertl K; Kaik B; Kaik G
    Clin Pharmacol Ther; 1993 Jan; 53(1):76-83. PubMed ID: 8422745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inotropic and chronotropic responses of the guinea pig and dog myocardium to isoprenaline and salbutamol.
    Hughson RL; Ledsome JR
    Can J Physiol Pharmacol; 1975 Apr; 53(2):231-8. PubMed ID: 236817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.
    Rahman AR; McDevitt DG; Struthers AD; Lipworth BJ
    Thorax; 1992 Dec; 47(12):1056-9. PubMed ID: 1494770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenoterol and salbutamol actions on guinea-pig myometrium: effects of ovarian steroids.
    Mammen GJ; Handberg GM; Story ME; Pennefather JN
    Eur J Pharmacol; 1987 Nov; 143(2):229-35. PubMed ID: 3691656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist.
    Chapman KR; Galko BM; Smith DL; Leenen FH
    Br J Clin Pharmacol; 1989 Feb; 27(2):268-71. PubMed ID: 2713221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
    Deenstra M; Haalboom JR; Struyvenberg A
    Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacologic characterization of formoterol in comparison with isoprenaline, fenoterol and salbutamol in tracheal muscle strips and lung membranes of the guinea pig].
    Lemoine H; Worth H; Reinhardt D
    Pneumologie; 1993 Apr; 47(4):303-10. PubMed ID: 8506253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.
    Cekici L; Valipour A; Kohansal R; Burghuber OC
    Br J Clin Pharmacol; 2009 Apr; 67(4):394-402. PubMed ID: 19371312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
    Smyth ET; Pavord ID; Wong CS; Wisniewski AF; Williams J; Tattersfield AE
    BMJ; 1993 Feb; 306(6877):543-5. PubMed ID: 8096416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.
    Lipworth BJ; McDevitt DG; Struthers AD
    Br J Clin Pharmacol; 1989 Jun; 27(6):837-42. PubMed ID: 2547409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man.
    Schmetterer L; Dallinger S; Polak K; Eichler HG; Wolzt M
    Nitric Oxide; 1999 Jun; 3(3):209-15. PubMed ID: 10442852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age.
    Bouillon T; Meineke I; Port R; Hildebrandt R; Günther K; Gundert-Remy U
    Eur J Clin Pharmacol; 1996; 51(2):153-60. PubMed ID: 8911881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.